History Of ROYESH-SCB
Established in 2011, ROYESH-SCB Institute was founded with the pioneering aim of advancing stem cell biotechnology research and education to revolutionize regenerative medicine. Based on our belief “no improvement is achieved unless the educational foundation is modified”, establishing the long-term advanced skill educational platforms in the field of biotechnology and stem cells was our first landmark achievement, which improves the scientific and research level of related students and equips them to whether find their desired job easier or do their upcoming projects with clearer insights. Inspired by the unmet clinical needs and scientific questions of the time, our early years were devoted to building a robust research team and forging our first collaborations with leading universities and research institutes.
Our institute’s second breakthrough occurred in 2015, when a cell bank comprising human, rat, and rabbit stem cell lines, as well as human cancer cell lines, was successfully established. These cell lines, as the first ROYESH-SCB Institute’s products, were utilized in various research projects and launched the first step of selling products to other institutes, hospitals, and universities.
Since 2020, when the “Biomaterials & Biomedical Sciences” research group was established, the designing and manufacturing of polymeric microspheres and nanoparticles by exploiting state-of-the-art technologies in parallel with conducting the related research projects was considered another ROYESH-SCB prospect.
Over the past decade, ROYESH-SCB Institute has grown into a multidisciplinary research hub, known for its commitment to innovation, high-impact science, and collaborative spirit. Our researchers and scientific research board members at this Institute have taken an effective step in establishing the esteemed position of the ROYESH-SCB Institute in the stem cell and biotechnology communities by publishing dozens of full-length articles with high impact, participating in international conferences around the world as invited speakers, and compiling and authoring several books and advanced skills training standards, and presenting cutting-edge innovations.
Looking ahead, we remain dedicated to bridging fundamental research and clinical application, striving to deliver life-changing therapies that rely on the latest advances in stem cell and biotechnology. We continue to push the boundaries of stem cells and biomedical sciences by conducting joint and synergistic collaborations and worldwide partnerships with both academic and industry leaders.